ADHD Medication: Benefits, Risks and Myths Explained – What the Evidence Really Says

Receiving an ADHD diagnosis can bring relief, clarity and, for some people, a new question:

Should I take medication for ADHD?

It is an understandable question.

Some people are concerned about side effects, dependence, changes in personality or whether medication is really necessary. Others have heard stories of ADHD medication transforming someone’s ability to concentrate, work or manage everyday life.

The reality is more nuanced.

ADHD medication is one of the main evidence-based treatment options for attention deficit hyperactivity disorder. Research shows that medication can reduce core ADHD symptoms for many children, young people and adults. However, it is not a cure, it does not work equally well for everyone, and treatment decisions should always be individualised.

For many people, the most effective approach involves a combination of medication, information about ADHD, practical strategies, appropriate adjustments and psychological support where needed.

What is ADHD medication designed to do?

ADHD is a neurodevelopmental condition associated with differences in attention, impulsivity and activity regulation. It can also affect executive functions involved in planning, organisation, working memory and completing everyday tasks.

Medication is intended to reduce ADHD symptoms and improve day-to-day functioning.

Depending on the individual, treatment may help with:

• sustaining attention
• concentration
• impulsivity
• organisation and planning
• completing tasks
• working memory
• managing distractions
• consistency in work or study
• everyday functioning.

The aim of treatment is not to change someone’s personality.

When medication is appropriate and well adjusted, it should help reduce some of the difficulties caused by ADHD while allowing the person to remain themselves.

If someone feels emotionally blunted, unusually withdrawn or significantly different from their normal self after starting medication, this should be discussed with the prescribing clinician.

How does ADHD medication work?

Several brain systems are involved in ADHD, including pathways involving the neurotransmitters dopamine and noradrenaline.

These chemical messengers contribute to processes including attention, behavioural inhibition, motivation, reward processing and executive functioning.

Stimulant ADHD medicines increase the availability or activity of dopamine and noradrenaline within relevant brain pathways.

Non-stimulant medicines work differently but can also influence noradrenergic and related systems involved in attention and impulse control.

This does not mean medication simply “creates motivation”.

Many people instead describe tasks as becoming easier to start, distractions becoming less intrusive or their thoughts feeling easier to organise.

The response varies considerably between individuals.

Which ADHD medications are used for adults in the UK?

Treatment should always be individualised and prescribed by an appropriately qualified healthcare professional.

Under NICE Guideline NG87, lisdexamfetamine or methylphenidate are recommended as first-line pharmacological treatments for adults with ADHD.

Methylphenidate

Methylphenidate is a stimulant medicine available in different formulations, including immediate-release and modified-release preparations.

Different formulations vary in how quickly they take effect and how long their effects last.

Lisdexamfetamine

Lisdexamfetamine is another stimulant medicine and is converted within the body into dexamfetamine.

NICE recommends considering a switch from methylphenidate to lisdexamfetamine, or vice versa, when an adequate trial of the first treatment has not provided sufficient benefit.

Dexamfetamine

NICE recommends considering dexamfetamine for adults whose ADHD symptoms respond to lisdexamfetamine but who cannot tolerate its longer duration of effect.

Atomoxetine

Atomoxetine is a non-stimulant medication.

For adults, NICE recommends atomoxetine when methylphenidate and lisdexamfetamine cannot be tolerated or when symptoms have not responded adequately to separate appropriate trials of these medicines.

What about guanfacine?

Guanfacine is used in ADHD treatment, particularly in children and young people.

However, NICE does not recommend routine guanfacine treatment for adults without advice from a tertiary ADHD service, and adult use is off-label.

There is therefore no single ADHD medicine that is “best” for everyone.

Choosing medication involves considering:

• symptoms
• functional impairment
• physical health
• mental health history
• other medicines
• side-effect profile
• duration of effect required
• patient preference
• previous treatment response.

How effective is ADHD medication?

ADHD medicines are among the most extensively studied treatments for ADHD.

A major network meta-analysis published in The Lancet Psychiatry compared ADHD medicines across children, adolescents and adults and found evidence that several medications were more effective than placebo at reducing core ADHD symptoms in the short term.

More recently, a large systematic review and network meta-analysis of treatments for adult ADHD, published in The Lancet Psychiatry in 2025, again found that pharmacological treatments were effective for reducing core adult ADHD symptoms, while emphasising differences in tolerability and the importance of individual treatment decisions.

The Royal College of Psychiatrists also recognises medication as an established component of evidence-based treatment for adult ADHD.

However, averages from clinical trials do not tell us exactly how one person will respond.

Some people experience substantial improvement.

Others notice moderate benefits.

Some experience side effects that outweigh the benefit or find that a particular medicine is not effective.

This is why ADHD medication is normally introduced through careful titration, gradually adjusting treatment while monitoring symptoms, functioning and adverse effects.

What improvements might people notice?

When medication is effective, people may notice improvements such as:

• being able to concentrate for longer
• completing tasks more consistently
• becoming less easily distracted
• finding it easier to organise work
• improved impulse control
• reduced restlessness
• improved ability to follow conversations
• fewer forgotten appointments or tasks
• greater consistency at work or in education.

Medication can also make it easier for some people to use behavioural and organisational strategies that previously felt difficult to maintain.

However, treatment goals should focus on real-world functioning, not simply whether someone feels more focused for a few hours.

A good medication review therefore considers questions such as:

• Is work becoming more manageable?
• Are important tasks being completed?
• Is home life functioning better?
• Are symptoms causing less impairment?
• Are side effects acceptable?

What ADHD medication cannot do

One of the most important parts of ADHD treatment is having realistic expectations.

Medication does not:

• cure ADHD
• instantly teach organisational skills
• automatically resolve relationship difficulties
• eliminate every ADHD symptom
• compensate for chronic sleep deprivation
• create routines on its own
• remove every source of stress
• guarantee improved work or academic performance.

Someone who has lived with ADHD for many years may also have developed avoidance patterns, low confidence, difficulties with routines or unhelpful coping strategies.

Those difficulties may need separate support.

Medication can make certain changes easier, but it does not make them automatic.

Common myths about ADHD medication

Myth 1: “ADHD medication changes your personality”

Appropriately prescribed treatment should not make someone feel as though they have lost their identity.

If medication produces significant emotional blunting, excessive quietness, irritability or a feeling of being unlike yourself, the treatment should be reviewed.

Sometimes a different dose, formulation or medicine may be more appropriate.

Myth 2: “Medication is only for severe ADHD”

Medication decisions are not based purely on the number of symptoms someone has.

NICE recommends considering the degree to which ADHD symptoms continue to cause significant impairment after environmental modifications and appropriate discussion about treatment options.

Someone may have symptoms that appear moderate but still experience substantial difficulties with work, education, relationships or everyday responsibilities.

Treatment decisions should therefore be based on the individual’s circumstances rather than a simple label of “mild” or “severe”.

Myth 3: “Medication cures ADHD”

ADHD is a neurodevelopmental condition.

Medication can reduce symptoms while the medicine is active, but it does not permanently remove ADHD.

Some people remain on medication long term, while others use it for particular periods or later decide with their clinician that they no longer need it.

Treatment should be reviewed over time.

Myth 4: “If medication works, you definitely have ADHD”

A positive response to stimulant medication is not a diagnostic test for ADHD.

People without ADHD may also experience changes in alertness or concentration when taking stimulant substances.

An ADHD diagnosis should be made through a proper clinical assessment considering developmental history, symptoms, impairment and alternative explanations.

What are the possible side effects?

All medicines can cause side effects.

The exact risks differ between medications and individuals.

Common adverse effects associated with stimulant ADHD medicines can include:

• reduced appetite
• difficulty sleeping
• headache
• dry mouth
• nausea or abdominal discomfort
• increases in heart rate
• increases in blood pressure.

NHS information also advises that some people taking methylphenidate can experience dizziness, visual disturbance or sleepiness.

Atomoxetine can also cause side effects including nausea, reduced appetite, sleep disturbance, dizziness, headache and changes in pulse or blood pressure.

Side effects should not simply be ignored.

The prescriber may adjust:

• the dose
• the timing
• the formulation
• the medication itself.

The aim is to find a balance between meaningful improvement and acceptable adverse effects.

What monitoring is required?

Before ADHD medication is started, NICE recommends a baseline assessment that includes relevant physical and mental health information.

This generally includes:

• current medicines
• medical history
• cardiovascular assessment
• blood pressure
• pulse
• height and weight
• assessment of potential substance misuse and diversion risk.

An ECG is not routinely required for everyone before stimulant, atomoxetine or guanfacine treatment when cardiovascular history and examination are normal and there are no other relevant cardiovascular risks.

Monitoring should continue after medication is started.

Blood pressure, pulse and weight are among the measures clinicians may monitor depending on the person’s age, treatment and circumstances.

Are ADHD medicines addictive?

This question deserves a careful answer.

Stimulant ADHD medicines can have misuse and abuse potential, which is one reason medicines such as methylphenidate and amphetamine-based treatments are controlled drugs in the UK.

They should only be taken exactly as prescribed and should never be shared with another person.

However, taking prescribed ADHD medication under appropriate clinical supervision is not the same as recreational stimulant misuse.

A large study involving nearly three million adolescents and adults with ADHD found that periods of prescribed ADHD medication were not associated with an increased risk of substance-related problems. In that study, medication periods were actually associated with lower rates of substance-related events.

That does not mean misuse is impossible.

Clinicians should consider the individual’s history and risk of:

• misuse
• substance dependence
• medication diversion
• taking higher doses than prescribed.

Medication should therefore always be prescribed and monitored appropriately.

What about heart risks?

Stimulant ADHD medicines and atomoxetine can produce small increases in heart rate and blood pressure in some people.

This is why cardiovascular history and physical monitoring form part of appropriate prescribing.

Evidence concerning serious cardiovascular outcomes is more complex.

A 2022 systematic review and meta-analysis found no statistically significant overall association between ADHD medication use and cardiovascular disease across age groups, although the authors noted that modest risks could not be completely excluded.

More recent observational studies have raised questions about possible increases in some cardiovascular risks with longer-term exposure, particularly at higher cumulative doses. These findings do not prove that medication causes cardiovascular disease, but they reinforce the importance of appropriate assessment and monitoring rather than assuming treatment is risk-free.

Anyone with:

• significant heart disease
• fainting
• unexplained chest pain
• concerning palpitations
• a strong family history of sudden cardiac death

should discuss this with their clinician before treatment.

Can ADHD medication affect sleep?

Yes.

Difficulty falling asleep can occur with stimulant treatment, particularly if the medication remains active late in the day.

However, ADHD itself can also be associated with sleep difficulties, so it is important not to assume medication is always the cause.

A clinician may consider:

• dose timing
• medication duration
• formulation
• caffeine intake
• existing sleep problems
• sleep routine.

Do not independently change the dose or timing of prescription medication without discussing it with your prescriber.

Can ADHD medication reduce appetite?

Reduced appetite is a common side effect of stimulant treatment and can also occur with atomoxetine.

For some people, appetite returns later in the day as medication effects wear off.

Weight should be monitored appropriately, particularly where there is significant weight loss or concern about nutrition.

If appetite suppression becomes problematic, speak to the prescribing clinician rather than simply stopping treatment.

Does ADHD medication improve emotional regulation?

Many people with ADHD describe emotional impulsivity, frustration or difficulty regulating reactions.

Some individuals report that medication helps them feel less reactive because they can pause, concentrate and respond more deliberately.

However, medication is primarily prescribed to treat core ADHD symptoms and associated impairment, and emotional difficulties may have several causes.

Persistent emotional dysregulation may require broader assessment and psychological support rather than assuming medication alone will resolve it.

Does medication work better alongside other forms of support?

For many people, yes.

ADHD treatment often works best when it addresses both symptoms and the practical consequences of living with the condition.

Depending on individual needs, this may include:

• psychoeducation
• cognitive behavioural approaches
• ADHD-focused psychological interventions
• organisational strategies
• workplace adjustments
• educational adjustments
• sleep support
• regular physical activity
• practical planning systems
• support for anxiety, depression or other coexisting conditions.

NICE recommends considering structured supportive psychological interventions for adults with ADHD when non-pharmacological treatment is indicated, and treatment should be adapted to the person’s needs.

Medication may make it easier to put these strategies into practice, but neither medication nor psychological intervention should automatically be assumed to suit everyone.

How long does it take to find the right ADHD medication?

There is no universal timeframe.

Treatment often involves a titration period in which the dose is gradually adjusted while the clinician and patient review:

• symptom improvement
• duration of benefit
• daily functioning
• sleep
• appetite
• mood
• pulse
• blood pressure
• other side effects.

Sometimes the first medicine works well.

In other cases, several doses, formulations or medications may need to be considered before an acceptable balance is found.

This is a normal part of individualised treatment rather than evidence that ADHD medication has “failed”.

Should everyone diagnosed with ADHD take medication?

No.

Medication can be very helpful, but it is not compulsory and it is not appropriate for everyone.

The decision should be shared between the individual and an appropriately qualified clinician.

Factors to discuss include:

• how ADHD affects everyday life
• treatment goals
• physical health
• mental health
• possible side effects
• previous medication experience
• other treatments available
• personal preferences.

People should have enough information to make an informed decision without being pressured either towards or away from medication.

Questions to ask before starting ADHD medication

Before beginning treatment, you may find it helpful to ask:

What improvements are we hoping to see?

Clear treatment goals make it easier to judge whether medication is actually helping.

What side effects should I look out for?

Different medications have different profiles.

How will my blood pressure, pulse and weight be monitored?

Monitoring is an important part of safe treatment.

How long should I try this dose before deciding whether it works?

Titration should be structured and clinically supervised.

What should I do if I miss a dose?

The answer varies according to the medicine and formulation.

Could this medicine interact with anything else I take?

Always give your prescriber a complete list of prescription medicines, over-the-counter products and relevant supplements.

What happens if this medication does not suit me?

There are different medication and non-medication options, so an unsuccessful first trial does not mean there are no further treatment choices.

The bottom line

ADHD medication is an established, evidence-based treatment for reducing core ADHD symptoms in many people.

For adults in the UK, NICE recommends lisdexamfetamine or methylphenidate as first-line pharmacological treatment, with other options considered according to response, tolerability and individual circumstances.

Medication can improve attention, impulse control and everyday functioning, but it is not a cure and it does not replace sleep, routines, practical strategies, psychological support or appropriate workplace and educational adjustments.

Like all medicines, ADHD treatments have potential side effects and risks. Safe treatment therefore requires an appropriate assessment, individualised prescribing, careful titration and ongoing monitoring.

For some people, medication can make a substantial difference.

For others, the benefits are smaller or a different treatment approach is more appropriate.

The aim is not simply to prescribe a tablet. It is to find a treatment plan that helps the individual function better while remaining safe, informed and involved in decisions about their care.

ADHD Assessment and Medication Support at Oxford Psychiatry Group

If you are considering an ADHD assessment or would like to discuss treatment following a diagnosis, Oxford Psychiatry Group provides specialist ADHD assessment and treatment services.

Our clinicians take an individualised approach, considering your symptoms, medical and psychiatric history, everyday difficulties, treatment goals and preferences before discussing appropriate options.

Where medication is suitable, treatment should include appropriate titration and monitoring in line with current clinical guidance.

To find out more about ADHD assessment and treatment, contact Oxford Psychiatry Group or book an initial consultation.

---

Medical disclaimer: This article is intended for general information and education only. It does not replace individual medical advice, diagnosis or treatment. ADHD medication should only be started, stopped or changed following advice from an appropriately qualified prescribing clinician.